CAMP HILL, Pa., May 30, 2017 -- Harsco Corporation (NYSE:HSC) announced today that Company management is participating in the KeyBanc Capital Markets Industrial, Automotive & Transportation Conference in Boston on May 31 and June 1, 2017. The Company will be represented by President and CEO Nicholas Grasberger at the event. Updated presentation materials will be available on the Company’s website at http://investors.harsco.com prior to the conference.
About Harsco Corporation
Harsco Corporation is a diversified industrial company providing a range of onsite services and engineered products to the global steel, energy and railway sectors. Harsco’s common stock is a component of the S&P SmallCap 600 Index and the Russell 2000 Index. Additional information can be found at www.harsco.com.
Investor Contact David Martin 717.612.5628 [email protected] Media Contact Kenneth Julian 717.730.3683 [email protected]


Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Disney Board Nears CEO Decision as Josh D’Amaro Emerges as Leading Candidate
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs
OpenAI Reportedly Eyes Late-2026 IPO Amid Rising Competition and Massive Funding Needs 



